Frontiers in Bioscience-Landmark (Jun 2022)

Expression of Novel Kinase MAP3K19 in Various Cancers and Survival Correlations

  • Khoa Nguyen,
  • Hassan Yousefi,
  • Thomas Cheng,
  • Justin Magrath,
  • Alifiani B. Hartono,
  • Madlin Alzoubi,
  • Katherine Hebert,
  • Courtney K. Brock,
  • Maryl K. Wright,
  • Charles Ethan Byrne,
  • Andrew Rivera,
  • Sam C. Okpechi,
  • Margarite Delores Matossian,
  • Henri Wathieu,
  • Steven Elliott,
  • Mark J. Mondrinos,
  • Sean B. Lee,
  • Bridgette M. Collins-Burow,
  • Suresh K. Alahari,
  • David H. Drewry,
  • Matthew E. Burow

DOI
https://doi.org/10.31083/j.fbl2706196
Journal volume & issue
Vol. 27, no. 6
p. 196

Abstract

Read online

Mitogen Activated Protein (MAP) kinases are a category of serine/threonine kinases that have been demonstrated to regulate intracellular events including stress responses, developmental processes, and cancer progression Although many MAP kinases have been extensively studied in various disease processes, MAP3K19 is an understudied kinase whose activities have been linked to lung disease and fibroblast development. In this manuscript, we use bioinformatics databases starBase, GEPIA, and KMPlotter, to establish baseline expressions of MAP3K19 in different tissue types and its correlation with patient survival in different cancers.

Keywords